Related Experiment Video
Updated: May 28, 2026

A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms
Published on: September 16, 2022
In Vitro Activity of (-)-Myrtenol on Adherence, Morphogenesis and Lipase Activity in Candida albicans Isolated from
Camila Mendes Soares1, Larissa Alves da Silva1, Luanna de Oliveira E Lima1
1Clinical Mycology Laboratory, Department of Pharmaceutical Sciences, Federal University of Paraíba, João Pessoa 58051-900, Paraíba, Brazil.
Abstract:
Candida albicans is a yeast found in the oral cavity, gastrointestinal tract, and vaginal mucosa. This species is the most prevalent and virulent in conditions such as oral candidiasis. Myrtenol is a bicyclic monoterpene alcohol recognized for its antioxidant and anti-inflammatory attributes. Its primary source is the essential oil extracted from plants of the Myrtaceae family. This study evaluated the effect of (-)-myrtenol on the virulence factors of Candida albicans. Ten clinical isolates of Candida albicans and one reference strain (ATCC 90028) were used in this study. The virulence factors examined included adhesion, morphogenesis, and lipase production. Assays were conducted in the presence and absence of (-)-myrtenol, using a concentration corresponding to the minimum inhibitory concentration (MIC; 256 µg/mL). Results: The compound reduced the adherence of C. albicans to human oral epithelial cells (92.24 vs. 28.69), and reduced filamentation in liquid (3.17 vs. 2.57) and solid media. Furthermore, (-)-myrtenol inhibited lipase activity (0.68 vs. 1.00). Virulence factors expressed by C. albicans contribute to increased infection rates and, consequently, increased morbidity and mortality. The present findings demonstrate that (-)-myrtenol affects virulence-associated phenotypes of C. albicans in vitro. This compound represents a promising candidate for further investigation, particularly in studies addressing its mechanisms of action, safety, and potential applicability.
Insights
(-)-Myrtenol significantly reduces virulence factors in Candida albicans, including adhesion, filamentation, and lipase production. This natural compound shows promise for combating C. albicans infections.
Area of Science:
- Microbiology
- Natural Products Chemistry
- Infectious Diseases
Background:
- Candida albicans is a prevalent yeast causing opportunistic infections like oral candidiasis.
- Myrtenol, a monoterpene alcohol from Myrtaceae essential oils, possesses antioxidant and anti-inflammatory properties.
- Virulence factors of C. albicans are crucial for infection establishment and progression.
Purpose of the Study:
- To investigate the impact of (-)-myrtenol on key virulence factors of Candida albicans.
- To assess the efficacy of (-)-myrtenol against clinical isolates and a reference strain of C. albicans.
Main Methods:
- Evaluated (-)-myrtenol's effect on C. albicans adhesion, morphogenesis (filamentation), and lipase production.
- Utilized ten clinical isolates and one reference strain (ATCC 90028) of C. albicans.
- Conducted assays in the presence and absence of (-)-myrtenol at its minimum inhibitory concentration (MIC).
Main Results:
- (-)-Myrtenol significantly reduced C. albicans adherence to human oral epithelial cells (92.24% vs. 28.69%).
- Reduced filamentation in both liquid (3.17 vs. 2.57) and solid media.
- Inhibited lipase activity (0.68 vs. 1.00).
Conclusions:
- (-)-Myrtenol effectively modulates critical virulence phenotypes of Candida albicans in vitro.
- This compound demonstrates potential as a therapeutic agent against C. albicans infections.
- Further research into (-)-myrtenol's mechanisms of action, safety, and applicability is warranted.
Related Concept Videos
Candidiasis
Antifungal Agents

